ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Readying Your Clinical Trial For Linkage With Real-World Data

  Discover why the near ubiquity of real-world data (RWD) sources has prompted sponsors to consider RWD’s role in study programs and regulatory bodies to issue guidance on their use in clinical development.

• Patient-Centricity Is In Everything We Do: Designing Accessible eClinical Technology

  By prioritizing patient centricity within an eClinical platform’s design, sponsors can tailor patient engagement to achieve outcomes based on a study’s indication, patient population, and end goals.

• How Heron Therapeutics Sped Up Database Creation

  Electronic data capture (EDC) is straightforward, in theory. However, not every EDC is purpose-designed for ease of use by study teams, and some are easier to use and more intuitive than others.

• Evaluating EDC Systems In A Modern DM Landscape

  This guide provides five crucial recommendations to refine evaluation strategies and choose the right solution for today's complex clinical data environment, optimizing data collection practices.

• Modern Post-Market Trials Driven By RWD – Is Your EDC Ready?

  Explore the transformative role of real-world data (RWD) and advanced Electronic Data Capture (EDC) systems in post-market research, marking a departure from traditional Phase IV trials.

• Navigating Wearable Integration: Key Operational Considerations

  Explore wearable devices' transformative potential and innovative capabilities for data collection, patient monitoring, and endpoint measurement.

• Why Oncology Drug Development Lags In Digital Biomarkers

  Despite technological advances, oncology drug development research has lagged in adopting wearable digital biomarkers. Explore this space's unique challenges and the benefits of wearable technology.

• Gradually Investing In Direct Data Capture Is Inevitable

  Given study decentralization and the many electronic sources of data now available, it is time for sponsors and contract research organizations to face the inevitable: EDCs need to be “sunsetted.”

• Why Are Sponsor Organizations Using More Than 1 CTMS Solution?

  Explore evolutions in the eClinical market, CTMS use in the outsourcing community, and the difficulty in keeping up with requirements that sponsor organizations, CROs, and clinical trial sites experience regarding their CTMS solutions.

• Modern Decentralized Trials Demand Advanced eClinical Support

  First-generation eClinical systems can create as many challenges as they resolve. A more coherent solution is necessary to ensure data integrity, ease site burdens, and promote greater patient-centricity.